The objectives of this observational sudy are as follows. Main objective is to determine the ability to maintain response after discontinuation of adalimumab treatment.
Secondary objective is to determine radiographic progression in patients participating in the study, including the proportion who display minimal progression.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01346501?cond=%22Arthritis%22&lup_s=08/23/2013&lup_d=30
